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Abstract. In medicine, there are many diseases which cannot be pre-
cisely characterized but are considered as natural kinds. In the communi-
cation between health care professionals, this is generally not problematic.
In biomedical research, however, crisp deﬁnitions are required to unam-
biguously distinguish patients with and without the disease. In practice,
this results in diﬀerent operational deﬁnitions being in use for a single dis-
ease. This paper presents an approach to compare diﬀerent operational
deﬁnitions of a single disease using ontological modeling. The approach is
illustrated with a case-study in the area of severe sepsis.
1 Introduction
Inmedicine,many diseases cannot be unequivocally deﬁned by etiology or anatom-
ical localization, but are instead described by a combination of signs and symptoms
that are common in patients believed to be suﬀering from that disease.
An example of such a disease is the syndrome of severe sepsis. In this disease
the immune system of the patient overreacts to an infection. If untreated, the pa-
tient becomes severely ill, which may result in organ failure and eventually death.
The cause of severe sepsis is largely unknown, and the disease is not restricted
to an exact anatomical localization, which hinders the precise characterization
of the patient.
In daily patient care and in communication between health care professionals
such a lack of precision is often not problematic. However, when the purpose of
describing patients is to select patients for medical research or to automatically
reason with patient data (e.g., in triggering computerized guidelines) a crisp
disease deﬁnition is required, which unambiguously distinguishes patients with
the disease from persons without the disease. In practice, this often results in ad
hoc, operational deﬁnitions that largely cover the intended patient group.
It is questionable to which extent patients selected by diﬀerent deﬁnitions can
be compared. This is an important issue in, for instance, statistical aggregation
of data, meta-analysis of medical scientiﬁc evidence, and in the design of clinical
studies.
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In previous work we have shown that nine recent clinical trials in the area of
severe sepsis all used diﬀerent operational deﬁnitions. Applying these deﬁnitions
onto real clinical data resulted in the selection of patient groups with diﬀerent
outcome characteristics [1].
In this paper we present an approach to systematically compare diﬀerent
operational deﬁnitions of a single disease using ontological modeling. First we
present a general abstraction hierarchy which indicates the levels at which the
concepts related to the operational deﬁnitions are expressed. Subsequently we
propose a method that uses this hierarchy to compare complex deﬁnitions at
diﬀerent levels of abstraction.
Throughout the paper we will use two operational deﬁnitions of severe sepsis
as an example, which are depicted in Table 1. When comparing these deﬁnitions,
we note that both deﬁnitions have polythetic aspects: a list of signs and symptoms
is given, of which a particular number has to be fulﬁlled, and some of which are
necessary conditions.
Table 1. Deﬁnitions for severe sepsis used in the PROWESS[2] and Kybersept[3] trial
PROWESS
Known or
suspected
infection
or signs of
pneumonia
At least three of the modiﬁed SIRS
criteria:
1)temperature ≥ 38◦C or
temperature ≤ 36 ◦C
2) heart rate ≥ 90/min
3) respiratory rate ≥ 20/min or
PaCO2 ≤ 32 mmHg or mechanical
ventilation
4)leukocyte count ≥12,000/mm3 or
leukocyte count ≤4,000/mm3 or
>10 % immature neutrophils
At least one out of:
1) pH ≤ 7.3 or base deﬁcit ≥ 5.0
mmol/L with plasma lactate > 1.5
times higher than normal
2) urine output < 0.5 mL/kg/hr
3) thrombocyte count
< 80 · 103 /mm3
4) PaO2/FiO2 ≤ 250 or ≤ 200 if no
other organ dysfunction present
5) systolic blood pressure < 90
mmHg or mean arterial pressure
≥ 70 mmHg or use of vaso-active
medication
Kybersept
Suspected
infection
temperature > 38.5◦C or tempera-
ture < 35.5 ◦C
AND
leukocyte count >10,000/mm3
or leukocyte count <3,500 /mm3
At least three out of:
1) heart rate > 100/min
2) respiratory rate >24/min or
mechanical ventilation
3) plasma lactate higher than nor-
mal or pH < 7.30 or base excess
-10 mmol/L
4) urine output < 20 mL/hr
5) thrombocyte count
<100 · 103/mm3
6) systolic blood pressure
< 90 mmHg or use of vaso-active
medication
2 Analyzing Diﬀerences in Deﬁnitions
This section describes the abstraction levels that can be distinguished in oper-
ational disease deﬁnitions (Section 2.1), and explains how these levels are used
in comparing diﬀerent deﬁnitions (Section 2.2).
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2.1 Levels of Operationalization
When describing a disease which is considered a natural kind, in fact, oper-
ationalization takes place at diﬀerent levels. These levels form an abstraction
hierarchy for concepts that are used in operational disease deﬁnitions, which is
depicted in Table 2. Four diﬀerent levels are distinguished. On the ﬁrst, most
abstract, level, concepts are expressed in terms of the condition of the patient.
The second level focuses on signs and symptoms. Signs and symptoms are fur-
ther operationalized using terms related to measurements that are performed in
the patient. On the fourth, most concrete, level, terms are used to describe the
threshold value for measurements, which distinguishes patients with the sign or
symptom from patients without.
When moving through the hierarchy from top to bottom the concepts be-
come more explicit. In daily patient care, it mostly suﬃces to use terms from
the ‘Condition’ and ‘Sign / Symptom’ levels. Instead, in operational deﬁnitions
used for purposes of selection, concepts are mostly expressed in terms of the
measurements with their threshold values.
2.2 Using the Operationalization Hierarchy in Comparing
Deﬁnitions
Diﬀerences between operational deﬁnitions occur at diﬀerent levels of opera-
tionalization. Identifying diﬀerences at the Threshold level is relatively straight-
forward, e.g., both severe sepsis deﬁnitions use the Measurement ‘Thrombocyte
count’, but Kybersept uses ‘< 100’ as a cut-oﬀ value, whereas PROWESS re-
quires the thrombocyte count to be lower than 80 ·103/mm3. It is however much
more complicated to see to which extent a deﬁnition that requires two speciﬁc
criteria to be present relates to a deﬁnition that requires three out of a list of four
criteria, such as in our example. Our approach helps to compare the deﬁnitions
not only at the lowest level of operationalization, but also at higher levels.
The approach consists of three steps. First, a ‘disease ontology’ is created, which
describes all possible operationalization choices for a speciﬁc disease in a formal-
ized way. Concepts for similar conditions that are operationalized in diﬀerent ways
Table 2. Abstraction hierarchy for concepts that are used in the operational deﬁnitions
of medical conditions
Level Description Example
Condition A collection of symptoms and/or signs of which a
given number has to be present for the condition
to be present.
Severe sepsis
Sign / Symptom A characteristic of the patient which is experi-
enced by the patient or can be measured by the
physician.
Platelet disorder
Measurement Result of a measurement performed by the physi-
cian.
Low thrombocyte count
Threshold value Threshold which determines whether the result of
the measurement indicates the sign / symptom to
be present.
Thrombocyte count ≤
80,000 mm3
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in the deﬁnitions are given diﬀerent names, e.g., KS-Thrombocytopenia and PW-
Thrombocytopenia. As formalization language we have used OWL DL, a language
recently recommended as a standard for ontology modeling based on Description
Logics [4], because it is able to 1) formalize concepts and complex relations (e.g.
number restrictions); 2) reason and query at diﬀerent levels; 3) be used in com-
bination with real patient data. A detailed description of the formalization of the
severe sepsis deﬁnitions is found in [5].
Second, each disease deﬁnition is formulated in terms of the disease ontology.
For each element of the deﬁnition is determined at which level it is speciﬁed, and
the appropriate concept from the disease ontology is chosen. In this step, we also
specify the polythetic conditions using number restrictions, e.g., KS-SevSepsis
 conditionOf.(> 3 hasSymptom.(or KS-Thrombocytopenia KS-Hypotension KS-
AbnormalHeartRate KS-AbnormalRespiratoryState KS-Oliguria KS-Acidosis)).
In the third step we compare the reformulated deﬁnitions automatically. The
question, “can the deﬁnitions be considered similar”, is easily answered by check-
ing for equivalence between the disease deﬁnitions. As this is often not the case,
in the second phase further comparisons aim to discover in which parts of the
deﬁnitions the diﬀerences are located. This comparison is based on enforcing
equivalence between concepts from diﬀerent deﬁnitions and checking for incon-
sistencies. This can be done at diﬀerent levels. To verify whether the thresholds
are similar, equivalence is enforced at the Measurements level. This will lead to
an inconsistency when the deﬁnitions make use of diﬀerent thresholds. To inves-
tigate whether the problem is located at the threshold level only, the ontology
can be ‘pruned’ unto the level of Measurements (i.e., at the threshold level the
concepts in both deﬁnitions are forced to be equivalent) and again checked for
equivalence of the deﬁnition and for inconsistencies. These comparisons can be
repeated at the higher, more abstract, levels.
For example, Figure 1 depicts a part of the ontology with some elements of
the Kybersept and PROWESS deﬁnitions of severe sepsis. When we test for
equivalence of the PROWESS and Kybersept concepts of ‘severe sepsis’ we will
ﬁnd that these two deﬁnitions are not equivalent (cf. Table 1). To ﬁnd out which
concepts or relations cause the diﬀerences, we start at the lowest level. When
enforcing equivalence between both ‘Low TC count’ measurements, we will ﬁnd
an inconsistency, as the trials use diﬀerent threshold values.
3 Discussion
In this paper we present an approach to systematically compare diﬀerent op-
erational deﬁnitions of a single disease using ontological modeling. Its use has
brieﬂy been illustrated with an example in the area of severe sepsis. More ex-
tensive examples of reasoning possibilities are given in [5].
The approach we have presented can be applied for several purposes. We
are implementing a web-service which assists trial designers in operationalizing
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Fig. 1. Part of the disease ontology with some elements of the Kybersept and
PROWESS deﬁnitions of severe sepsis. (TC count = thrombocyte count).
disease deﬁnitions.1 Current decision-support systems for trial designers focus
mainly on procedural, safety, and ethical aspects of the trial protocol (e.g, [6]),
whereas in our approach the focus is on the operational deﬁnition of the disease.
The approach can also be used in meta-analysis of scientiﬁc medical results, and
in the area of development of computerized versions of clinical guidelines.
In the current DL model we did not use datatype properties to model the
‘Threshold’ level, but instead created artiﬁcial concepts which were in a sub-
sumption relation (e.g., we used VeryLowTCCount-lt80, which is a subclass of
LowTCCount-lt100) . In future work we will enhance our approach to allow for
more complex reasoning at this lowest level. Furthermore, we will extend the
current model with an A-box with real patient data to combine querying the
knowledge-based model with querying patient data.
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